RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Emerging Role of the p53 Pathway in Modulating NK Cell-Mediated Immunity.
Emerging Role of the p53 Pathway in Modulating NK Cell-Mediated Immunity.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
p53通路在癌症免疫中发挥着重要作用。p53通路中蛋白的突变或下调在许多癌症中普遍存在,促进肿瘤进展和免疫失调。最近的研究发现,肿瘤细胞、免疫细胞和肿瘤微环境中p53的活性在调节NK细胞介导的免疫中可能发挥重要作用。因此,恢复p53通路活性的努力正在积极进行,以调节这种形式的免疫。本综述聚焦于p53活性调控肿瘤免疫微环境中NK细胞的浸润和激活。此外,还综述了p53及其对NK细胞的调控对实体瘤中免疫原性细胞死亡和远隔效应的影响。最后,讨论了未来通过治疗性恢复p53活性来改善NK细胞介导的抗肿瘤免疫并优化癌症治疗效果的途径。
The p53 pathway plays an important role in role in cancer immunity. Mutation or downregulation of the proteins in the p53 pathway are prevalent in many cancers, contributing to tumor progression and immune dysregulation. Recent findings suggest that the activity of p53 within tumor cells, immune cells, and the tumor microenvironment can play an important role in modulating NK cell-mediated immunity.
Consequently, efforts to restore p53 pathway activity are being actively pursued to modulate this form of immunity. This review focuses on p53 activity regulating the infiltration and activation of NK cells in the tumor immune microenvironment.
Furthermore, the impact of p53 and its regulation of NK cells on immunogenic cell death within solid tumors and the abscopal effect are reviewed.
Finally, future avenues for therapeutically restoring p53 activity to improve NK cell-mediated antitumor immunity and optimize the effectiveness of cancer therapies are discussed.
MEMBER ACCOUNT
登录成功会直接打开下一页。